Document Type

Article

Publication Date

6-18-2025

Comments

This article is the author's final published version in Clinical Infectious Diseases, Volume 81, Issue 3, September 15, 2025, Pages 416–426.

The published version is available at https://doi.org/10.1093/cid/ciaf225.. Copyright © The Author(s) 2025.

Abstract

BACKGROUND: The clinical consequences of repeated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not clear, especially as they relate to long-term symptoms after infection. We analyzed data collected for the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) to determine whether reinfection changes the likelihood of symptoms 3-6 months after reinfection compared with the likelihood in individuals experiencing a single infection.

METHODS: Individuals reporting a single SARS-CoV-2 infection or a single reinfection were included in this analysis. A positive SARS-CoV-2 test occurring ≥90 days after a first infection was considered a reinfection. Outcomes included severe fatigue (fatigue severity score ≥25) and the presence of organ system symptoms 3-6 months after the last infection.

RESULTS: The analysis included 886 individuals, 415 (46.8%) of whom experienced reinfection. For individuals who experienced their first infections in either the pre-Delta or Delta periods, the odds of having ≥3 symptoms 3-6 months after their most recent infection was lower in those reinfected than those with a single infection (weighted adjusted odds ratio, 0.45 [95% confidence interval, .21-.95] and 0.51 [.32-.79], respectively). However, in individuals reporting their first infection during the Omicron wave, the odds of reporting ≥3 symptoms after the most recent infection was higher in those reinfected than in those with a single infection (weighted adjusted odds ratio, 1.54 [95% confidence interval, 1.02-2.34]).

CONCLUSIONS: The timing of initial infection, reinfection, and the variants involved may play important roles in longer-term clinical outcomes. Repeated infection with Omicron variants may increase the risk of long-term symptoms.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Supplementary Data.docx (5241 kB)
Supplementary Data

Supplementary Figure 1.pptx (897 kB)
Supplementary Figure 1

Supplementary Figure 2.pptx (1174 kB)
Supplementary Figure 2

Supplementary Figure 3.pptx (1247 kB)
Supplementary Figure 3

Supplementary Figure 4.pptx (1111 kB)
Supplementary Figure 4

PubMed ID

40576557

Language

English

Share

COinS